Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 26 November 2021, 21:00 HKT/SGT
Share:
    

Source: MobiusTrend Research
MobiusTrend Reports: Rising of China's Civilian Restaurant

Shenzhen, China, Nov 26, 2021 - (ACN Newswire) - MobiusTrend releases the insight research report on ' Rising of China's Civilian Restaurant'. In China, a restaurant with good taste and reasonable price is called Civilian Restaurant. Unlike the luxury of star hotels, civilian restaurants are often more appealing to local residents because they offer better prices and have a touch of traditional Chinese culture. 'Shatou Four-Season' is a representative of Civilian Restaurant, which has grown from a small restaurant of 20 square meters to a famous restaurant brand after nearly 10 years of development.





On the eve of Thanks-giving, AR Cheng, CEO of 'Shatou Four-Season Catering Group' announced that they hit 270,000 followers on Douyin (TikTok in China). AR Cheng, like most local villagers in Shenzhen, China, is a pragmatic businessman. "The diners who come to our restaurant eat over 20,000 oysters a day, and that number is growing quickly!", says AR Cheng.

"Oysters, along with other seafood items, are the favorite dish of most of our guests. The Chinese people are richer, so they are more willing to come and spend money. Our TikTok account, with more than 270,000 followers, comes from customers of my restaurant. They not only like the food, but they also like to share food information to their friends. They use social media platforms like Dianping, TikTok, Wechat, Weibo to share their opinions."





For more information of Shatou Four-Season story, visit Douyin (TikTok in China), Dianping, QQ Video.

AR Cheng, on the other hand, is one of the many smart and hardworking people in China. And the rise of Civilian Restaurant also represents the steady rise in income levels of its residents.

Detail of the research report, please visit: http://www.mobiustrend.com/

About MobiusTrend

MobiusTrend Group is a leading market research organization in Hong Kong. They have built one of the premier proprietary research platforms on the financial market, emphasizing on emerging growth companies and paradigm-shifting businesses. MobiusTrend team is professional in market research reports, industry insights, and financing trends analysis. For more information, please visit http://www.mobiustrend.com/

Media contact
Company: MobiusTrend Research
Contact: Trends & Insights Team
E-Mail: cs@mobiustrend.com
Website: http://www.mobiusTrend.com

SOURCE: MobiusTrend Research




Topic: Press release summary
Source: MobiusTrend Research


http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
Philippine Airlines' Flash Sale Offers Up to 40% Off Base Fares Until July 17 Only  
July 17, 2026 13:48 HKT/SGT
Riyadh Emerges as a Global Powerhouse as Blockchain Infrastructure & AI Take Center Stage at Global Blockchain Show 2026  
July 17, 2026 12:58 HKT/SGT
AI-Driven LiveOps and Mobile Dominance Take Center Stage at Global Games Show Riyadh 2026  
July 17, 2026 12:14 HKT/SGT
JCB Celebrates 30 Years of Trust, Honoring 70 Years of Japan-Philippines Friendship  
Friday, July 17, 2026 9:00:00 AM
CTF Life Becomes First Insurer to Forge Long-term Strategic Partnership with Tencent Music Entertainment Group to Debut TIMA in Hong Kong This August  
July 17, 2026 08:27 HKT/SGT
TANAKA Commences Operation of "TANAKA H2 Nexus", One of Japan's Largest 500 kW Pure Hydrogen Fuel Cell Power Generation Facilities  
Thursday, July 16, 2026 9:00:00 PM
Community Creates Mega Artwork for HKTDC 60th Anniversary  
July 16, 2026 19:15 HKT/SGT
Cornerstone Robotics to Present at the 2nd Global Health Summit (GHS 2026)  
July 16, 2026 14:07 HKT/SGT
LEQEMBI(R) Real-World LEADER Study Presented at AAIC(R) 2026 Finds Over 75% of Early Alzheimer's Patients Enrolled in the Study Remained Stable and Nearly 7% Improved Over an Average of 17 Months of Treatment  
Wednesday, July 15, 2026 11:18:00 PM
FDA Approves LEQEMBI IQLIK(R) (lecanemab-irmb) Subcutaneous Injection as an Initiation Dose for Early Alzheimer's Disease  
Wednesday, July 15, 2026 10:51:00 PM
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: